UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054201
Receipt number R000061834
Scientific Title Low-dose L-DOPA treatment for drug-induced dystonia
Date of disclosure of the study information 2024/04/19
Last modified on 2024/04/19 16:08:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Low-dose L-DOPA treatment for drug-induced dystonia

Acronym

Low-dose L-DOPA treatment for drug-induced dystonia

Scientific Title

Low-dose L-DOPA treatment for drug-induced dystonia

Scientific Title:Acronym

Low-dose L-DOPA treatment for drug-induced dystonia

Region

Japan


Condition

Condition

Drug-induced dystonia

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to demonstrate the effectiveness of low-dose LDOPA oral treatment in relieving the motor and psychiatric symptoms caused by drug-induced dystonia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Yale Brown Obsessive Compulsive Scale (Y-BOCS)
Burke Fahn Marsden Dystonia Movement Scale (BFMDMS).

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients who meet the selection criteria will be prescribed low doses of LDOPA.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

The subjects in our study were patients diagnosed with drug-induced dystonia based on the DSM-V diagnostic criteria.

Key exclusion criteria

Other cases considered unsuitable for this study

Target sample size

9


Research contact person

Name of lead principal investigator

1st name Shinichi
Middle name
Last name Matsumoto

Organization

Osaka Neurological Institute

Division name

Neurology

Zip code

5610836

Address

2-6-23 Shounai Takaramachi Toyonaka Osaka

TEL

0663330086

Email

dyt1mc@yahoo.co.jp


Public contact

Name of contact person

1st name Shinichi
Middle name
Last name Matsumoto

Organization

Osaka Neurological Institute

Division name

Neurolody

Zip code

5610836

Address

2-6-23 Shounai Takaramachi Toyonaka Osaka

TEL

0663330086

Homepage URL


Email

dyt1mc@yahoo.co.jp


Sponsor or person

Institute

Osaka Neurological Institute

Institute

Department

Personal name



Funding Source

Organization

Osaka Neurological Institute

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Neurological Institute / IRB

Address

2-6-23 Shounai Takaramachi Toyonaka Osaka

Tel

0663330086

Email

dyt99mc@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 04 Month 18 Day

Date of IRB

2024 Year 04 Month 18 Day

Anticipated trial start date

2024 Year 04 Month 18 Day

Last follow-up date

2026 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 19 Day

Last modified on

2024 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061834


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name